Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial

Khonche Ahmad; Huseini Hasan Fallah; Gholamian Mandi; Mohtashami Reza; Nabati Farzaneh; Kianbakht Saeed

首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial

【24h】

Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial

机译：标准化的Nigella sativa种子油改善了肝脏脂肪变性，氨基转移酶和脂质水平的非酒精脂肪肝疾病：随机，双盲和安慰剂控制的临床试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Ethnopharmacological evidence: Nigella sativa (N. sativa) seeds are used in the Iranian traditional medicine for the treatment of liver diseases.

机译：民族科医生证据：Nigella sativa（N. sativa）种子用于伊朗传统医学治疗肝病。

著录项

来源
《Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs》 |2019年第2019期|共6页
作者
Khonche Ahmad; Huseini Hasan Fallah; Gholamian Mandi; Mohtashami Reza; Nabati Farzaneh; Kianbakht Saeed;
展开▼
作者单位

Baqiyatallah Univ Med Sci Dept Internal Med Tehran Iran;

ACECR Inst Med Plants Med Plants Res Ctr Karaj Iran;

Baqiyatallah Univ Med Sci Dept Internal Med Tehran Iran;

Baqiyatallah Univ Med Sci Quran &

Hadith Res Ctr Med Tehran Iran;

ACECR Inst Med Plants Med Plants Res Ctr Karaj Iran;

ACECR Inst Med Plants Med Plants Res Ctr Karaj Iran;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Nigella saliva; Non-alcoholic fatty liver disease;

机译：Nigella sativa;非酒精性脂肪肝病;

相似文献

外文文献
中文文献
专利

1. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial [J] . Khonche Ahmad, Huseini Hasan Fallah, Gholamian Mandi, Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs . 2019,第期

机译：标准化的Nigella sativa种子油改善了肝脏脂肪变性，氨基转移酶和脂质水平的非酒精脂肪肝疾病：随机，双盲和安慰剂控制的临床试验
2. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial [J] . Sangouni Abbas Ali, Azar Mohammad Reza Mohammad Hosseini, Alizadeh Mohammad The British Journal of Nutrition . 2020,第4期

机译：大蒜粉对非酒精性脂肪肝病患者肝硬化，肝脏酶和脂质曲线的影响：双盲随机对照临床试验
3. Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial [J] . Song Lihua, Zhao Xin Gang, Ouyang Peng Ling, The British Journal of Nutrition . 2020,第10期

机译：N-3脂肪酸和植物甾醇酯对非酒精性脂肪肝病受试者缓解肝硬化的综合作用：双盲安慰剂对照临床试验
4. The influence of hepatic steatosis on the evaluation of fibrosis with non-alcoholic fatty liver disease by acoustic radiation force impulse [C] . Yanrong Guo, Haoming Lin, Xinyu Zhang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2017

机译：肝硬化对辐射力冲击对非酒精性脂肪肝病纤维化评价的影响
5. AAV9-Mediated (Pro)Renin Receptor Antagonism Reduces High Fat Diet Induced Hyperglycemia and Hepatic Steatosis in Mouse Model of Non-Alcoholic Fatty Liver Disease [D] . Afrin, Sanzida. 2020

机译：AAV9介导（Pro）肾素受体拮抗作用降低了高脂肪饮食的非酒精脂肪肝病小鼠模型中的高脂肪饮食和肝脏脂肪变性
6. Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial [O] . Haleh Chehrehgosha, Masoud Reza Sohrabi, Faramarz Ismail-Beigi, 2021

机译：empagliflozin改善了患有非酒精脂肪肝疾病患者的肝脏脂肪变性和纤维化以及2型糖尿病：随机双盲安慰剂控制的临床试验
7. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial [O] . Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, 2019

机译：纳米姜黄素可改善葡萄糖指数，脂质，炎症和Nesfatin，超重和肥胖患者的非酒精脂肪肝病（NAFLD）：双盲随机安慰剂对照临床试验

Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅